Register an account to search through 14,000+ stocks! 

Ad

OMI – Owens & Minor Inc

Ad

Compliant

★★☆☆☆

Industry: Medical Equipment, Supplies & Distribution | NYSE

Owens & Minor Inc is Shariah compliant. The company’s financials pass two standards and fail in three.

Market cap: 2,743 MRev. Growth: 86.66%

AAOIFI ✗

Debt/MC34.54%
Non-Compliant Assets/MC%

S&P ✗

Debt/36 mo MC56.77%
Cash/36 mo MC3.34%
AR/36 mo MC41.91%

DJIM ✗

Debt/24 mo MC39.68%
Cash/24 mo MC2.33%
AR/24 mo MC29.3%

FTSE ✓

Debt/Assets26.79%
Cash/Assets1.58%
Cash&AR/Assets21.36%

MSCI ✓

Debt/Assets26.79%
Cash/Assets1.58%
Cash&AR/Assets21.36%

Recommendation Rating

2.14

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 57

Low: 43

High: 70

Total Analysts: 6


Owens & Minor, Inc. is a global healthcare solutions company. It operates through two segments: Global Solutions and Global Products. The Global Solutions segment includes its United States distribution businesses (Medical Distribution and Patient Direct), outsourced logistics and value-added services business. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own products. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. Its Global Products segment manufactures and sources medical surgical products through its production and kitting operations. Its home healthcare portfolio provides a range of chronic and acute care needs, including diabetes, ostomy, incontinence, wound care, home respiratory, obstructive sleep apnea and negative pressure wound therapy. Its manufacturing facilities are located in the United States, Thailand, and others.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan.

To understand how the screening is done, please read the Shariah Screening Methodology page.

Ad

Responses